Navigation Links
Transitioning epithelial cells to mesenchymal cells enhances cardiac protectivity
Date:12/23/2013

Putnam Valley, NY. (Dec. 23, 2013) Cell-based therapies have been shown to enhance cardiac regeneration, but autologous (patient self-donated) cells have produced only "modest results." In an effort to improve myocardial regeneration through cell transplantation, a research team from Germany has taken epithelial cells from placenta (amniotic epithelial cells, or AECs) and converted them into mesenchymal cells. After transplanting the transitioned cells into mice modelling a myocardial infarction, the researchers found that the epithelial-to-mesenchymal transition (EMT) was beneficial to cardiac regeneration by lowering infarct size. They concluded that EMT enhanced the cardioprotective effects of human AECs.

The study will be published in a future issue of Cell Transplantation but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1046Roy.

The authors noted that AECs have been shown to share characteristics of pluripotent cells that are able to transform into all other kinds of cells, and that their isolation and clinical-grade expansion of AECs is "relatively straightforward."

"Our hypothesis was that EMT would improve cardiac regeneration capacity of amniotic epithelial cells by increasing their mobility and extracellular matrix modulating capacity," said study corresponding author Dr. Christof Stamm of the Berlin Brandenburg Center for Regenerative Therapies, Berlin, Germany. "Indeed, four weeks after the mice were modeled with myocardial infarction the mice subsequently treated with EMT-AECs were associated with markedly reduced infarct size."

According to the researchers, as a result of the EMT process the AECs lost their "cobblestone" structure and acquired a fibroblastoid shape which was associated with a number of biological alterations that ultimately aided their mobility and altered their secretions.

One direct result of the EMT-AEC treatment was that EMT-AEC-treated hearts displayed "better global systolic function and improved longitudinal strain rate in the area of interest."

The researchers added that while AECs may be useful in the context of cardiovascular regeneration, it is unclear whether the usefulness requires "actual stemness" or "pluripotency-unrelated secretory mechanisms."

"Blood vessel density was increased in both AEC and EMT-AEC-treated hearts and we conclude that EMT enhances the cardioprotective effects of human AECs," they wrote.

"This study highlights how AECs are a potentially useful stem cell population whose use can be maximized by a transformation, such as EMT, prior to transplantation" said Dr Amit N. Patel, director of cardiovascular regenerative medicine at the University of Utah and section editor for Cell Transplantation. "This was demonstrated in a myocardial infarction model but further study is necessary to confirm whether this transformation is relevant for other diseases (and other cell types)".


'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Young adults with autism found to have difficulty transitioning into employment
2. A flip of the mitotic spindle has disastrous consequences for epithelial cells
3. How the cells remove copper
4. Enlisting cells protein recycling machinery to regulate plant products
5. Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation
6. Preferable treatment for MS found in allogenic bone marrow stem cells
7. Scientists find a groovy way to influence specialization of stem cells
8. Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
9. New hope for stem cells, regenerative medicine emerges from the lab
10. Microprinting leads to low-cost artificial cells
11. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... ... September 10, 2018 , ... IONpathTM, a venture-backed ... new Multiplexed Ion Beam Imaging (MIBITM) technology was accepted by the journal Cell ... be shared during a webinar presented by Dr. Mike Angelo on October 2nd, ...
(Date:9/12/2018)... ... September 12, 2018 , ... JoVE, the leading ... to support the professional development of academic librarians by sponsoring four award-winners to ... were asked to submit successful strategies to increase collaboration among librarians and STEM ...
(Date:9/7/2018)... ... September 05, 2018 , ... Following up on ... late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed ... The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... ... September 06, 2018 , ... ... neuromuscular disease, has been validated to be as effective as manual pathology. The ... Staining in Frozen Muscle Biopsies,” was published in the Archives of Pathology & ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis ... today the successful completion of a $5.5 million funding round managed by Commenda ... Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment in Nanovis is consistent ...
(Date:8/29/2018)... BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... optimization firm for the life sciences and healthcare industries, announces that Manu Vohra will ... on August 30th. , What: “How to Implement Box for GxP in 30 ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... and commercialization, has just released a new paper discussing systems engineering for ... Mario Kossmann, ESEP at the 28th Annual INCOSE International Symposium, the paper ...
Breaking Biology Technology: